COLA Ledger

An independent reference — not affiliated with the Social Security Administration. Every figure traced to the government publication that produced it.

The immunosuppressive drug benefit premium in 2026

Medicare eligibility based on end-stage renal disease normally ends 36 months after a successful kidney transplant. The Part B-ID benefit exists so that the anti-rejection drugs keep being covered after that point — and nothing else does.

2026 Part B-ID standard monthly premium

$121.60

Against the full Part B standard premium of $202.90. It is a narrower benefit at a lower price, not a discount on the same coverage.

Part B-ID premium
$121.60immunosuppressive drugs only
Full Part B premium
$202.90all Part B services
Difference
$81.30a month
Over a year
$1,459Part B-ID

What it covers, and what it does not

Part B-ID pays for immunosuppressive drugs and nothing else. It is not a substitute for Part B: doctor visits, outpatient care, lab work, durable equipment and every other Part B service are outside it. Someone enrolled in Part B-ID does not have Medicare in the ordinary sense — they have drug coverage that keeps a transplant working.

The benefit is separately premium-rated, and the premium is not withheld from a Social Security payment the way standard Part B is for most people. The ledger pages on this site deduct the standard Part B premium, not this one.

2026 Part B-ID against standard Part B
Part B-IDStandard Part B
Standard monthly premium$121.60$202.90
Annual deductible$283
ScopeImmunosuppressive drugsAll Part B services

The ten-cent gap is real

Part B immunosuppressive-drug IRMAA amounts run about 10 cents below the full Part B amounts at each tier ($81.10 vs $81.20). That is a real artifact of the statute's application, not a transcription error, and must not be "corrected".

It looks like a transcription error and it is not: the income-related amounts for Part B-ID are computed against the Part B-ID actuarial rate rather than the full Part B one, so the two ladders run parallel but never quite coincide. An ingest that “corrected” the gap would be introducing an error, not removing one. This site preserves it and says so.

Related

Sources and freshness

Figures effective 1 January 2026. Page figures last verified against the sources above on 10 August 2026. Corrections: the correction log · support@inventum.com.au